SYSDIAGNO

Nanjing, China · Founded 2012 · Privately Held (backing)

Manufacturer of in vitro diagnostic kits designed for early detection of liver cancer in patients with chronic hepatitis B and cirrhosis. SYSDIAGNO is based in Nanjing, China and was founded in 2012. It has raised $14.8 million.

Last price · $/share
—
Implied valuation
—
Total raised
$14.8M
Last round
—

Who backs SYSDIAGNO?

9 investors
InvestorType
CICC CapitalPE / buyout
Beijing Bohua CapitalVenture capital
Nanjing Industrial Development FundOther
RayStone CapitalOther
Fosun Pharma—
Guangdong Xingzhi—
Momentum Venture—
Nanjing Jiangbei New Area Science and Technology Investment Group—
Nanjing Tongren Boda Venture Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

SYSDIAGNO investors

9 investors are on record for SYSDIAGNO, including CICC Capital, Beijing Bohua Capital, Nanjing Industrial Development Fund and RayStone Capital.

Free account
More of SYSDIAGNO with a free account
  • ·Watch SYSDIAGNO: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like SYSDIAGNO. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View